Diabetic retinopathy impact on intraocular pressure during corticosteroid therapy
Офтальмохирургия, 2022 Purpose. Evaluation the impact of various types of diabetes mellitus, diabetic retinopathy and frequency of IVI injections of Ozurdex® on ophthalmic hypertension and its correction. Material and methods.
E. N. Khomyakova +2 more
doaj +1 more source
Herpes zoster masquerading viral endophthalmitis after ozurdex intravitreal implant
Indian Journal of Ophthalmology. Case Reports, 2022 A 64-year-old gentleman presented with decreased vision, raised intraocular pressure, and anterior chamber reaction of 1+ with grade 3 vitreous exudates on day 5 after intravitreal Ozurdex® implant.
Abhinav Dhami +2 more
doaj +1 more source
Intravitreal Ozurdex® in non-intact posterior lens capsule: case series and dilemma
Malaysian journal of ophthalmology, 2022 Background: Intravitreal Ozurdex® has been reported to be effective in treating macular oedema. It is more frequently used in resistant diabetic macular oedema cases that do not respond to anti vascular endothelial growth factor treatment.
A. Atikah +7 more
semanticscholar +1 more source
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment. [PDF]
Graefes Arch Clin Exp Ophthalmol, 2016 PurposeTo review published data pertaining to the clinical experience with a dexamethasone intravitreal implant (Ozurdex®) with a view to establishing a clinically based therapeutic regime.MethodsA PubMed search using the MeSH terms “retinal vein ...
Garweg JG, Zandi S.
europepmc +2 more sources
Efficacy and safety of intravitreal dexamethasone implant (Ozurdex®) in real-life practice
, 2022 Millions of patients worldwide suffer from macular edema and associated loss of visual acuity. Luckily, the range of available treatments has widened over the past few years including the dexamethasone sustained-release implant (Ozurdex®) - a ...
Malcles, Ariane
core +1 more source
Einfluss der initialen Therapiestrategie zur Behandlung des Makulaödems bei retinalen venösen Gefäßverschlüssen auf die Ergebnisse – Vergleich von intravitrealen Anti-VEGF-Präparaten mit einem intravitrealen Dexamethason-Implantat unter Alltagsbedingungen [PDF]
, 2021 Background Macular edema is a major complication of retinal venous occlusion (RVO). VEGF inhibitors – ranibizumab (Lucentis®), aflibercept (Eylea®), bevacizumab (Avastin®, off-label) – and a dexamethasone implant (Ozurdex®) are used in Germany to treat
Trojan, Barbara Anna
core +1 more source
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant [PDF]
, 2015 A 52-year-old woman undergoing azathioprine treatment for rheumatoid arthritis developed acute retinal necrosis a month after intravitreal dexamethasone (Ozurdex ®) implantation for posterior uveitis in the left eye.
Umit Yolcu (5762666) +7 more
core +1 more source
Accidental Intralenticular Injection of Ozurdex® for Branch Retinal Vein Occlusion: Intact Posterior Capsule and Resolution of Macular Edema. [PDF]
Case Rep Ophthalmol Med, 2019 Purpose We present a case of accidental intralenticular injection of Ozurdex implant in a patient with macular edema secondary to branch retinal vein occlusion. Method A case report. Results Intravitreal dexamethasone implant injection had been performed
Kurt A +2 more
europepmc +2 more sources
, 2022 Objectives To evaluate the duration and long-term efficacy of intravitreal injection of ranibizumab (IVR) combined with Ozurdex® (DEX) in the treatment of retinal vein occlusion with macular edema (RVO-ME).Methods This retrospective case study included
Xue-Mei Liang +4 more
semanticscholar +1 more source
Open Ophthalmology Journal, 2022 The aim of this study is to assess the real-life effectiveness and safety of intravitreal Ozurdex in an Irish setting. Ozurdex is an intravitreal dexamethasone implant that is used for the treatment of macular oedema secondary to retinal vein ...
Bobby Tang +3 more
semanticscholar +1 more source